 effects diastereomers adenosine cyclic 3',5'-phosphorothioate, (Sp)- (Rp)-cAMPS, kinetic properties pyruvate kinase studied hepatocytes isolated fed rats. Incubation cells cAMP-dependent protein kinase agonist, (Sp)-cAMPS, produced concentration-dependent increase S0.5 phosphoenolpyruvate, effect Vmax. (Sp)-cAMPS-treated enzyme sensitive inhibition alanine ATP and, conditions, less responsive activation fructose-1,6-bisphosphate assayed subsaturating phosphoenolpyruvate concentration. Incubation hepatocytes cAMP-dependent protein kinase antagonist, (Rp)-cAMPS, produced change kinetic parameters, suppress (Sp)-cAMPS- glucagon-induced increase S0.5 phosphoenolpyruvate IC50 values 10 microM 5 microM (Rp)-cAMPS. (Rp)-cAMPS exerting effect kinetic properties pyruvate kinase inhibition cAMP-dependent protein kinase.